Wall Street Calls This Gigawatt Pivot for AI Stocks
AI ambitions collide with power limits. This article explains the gigawatt pivot, why it matters for investors, and w...
What You Should Know About Travel Credit Cards
Travel credit cards come with various features that can enhance your travel experience. Learn essential insights to maximize your benefits.
25,344 articles
Intel Doubled AMD’s 2026 Gains, Should You Rebalance Now?
Intel has surged ahead in 2026, outpacing AMD by more than double in year-to-date gains. The rally prompts investors ...
XRP Forecast Sparks Debate: Nobody Wants Admit Google
Google Gemini AI has nudged XRP back into the spotlight with a bold price target for 2026. This report breaks down wh...
JEPI’s Covered-Call Strategy Could Deliver Consistent Income
A steady-income approach from JEPI tests traditional retirement cash flow models as market volatility shapes option p...
Allstate’s Deep-Value Edge Tops Progressive in Q1 2026
Allstate beats on underwriting and returns capital, while Progressive shows growth but a steadier combined ratio. The...
Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
Reasons Broadcom Could Be Better AI Play Than Nvidia
Nvidia dominates AI GPUs, but Broadcom could offer a different path into AI growth. This article lays out three concr...
This Alphabet-Heavy Fund Front-Row to AI Boom Surges
A concentrated AI-focused fund with a heavy tilt to Alphabet has surged as demand for AI infrastructure and software ...
Tesla's China Sales Just Jumped 22%: Is It Real Right Now?
Tesla's China Sales Just Jumped 22% in May, ending a slump. This article breaks down what's behind the rebound, wheth...
OpenAI IPO May Not Happen Soon, Veteran Journalist Says
A veteran journalist says that while IPO chatter around OpenAI persists, the path to a public listing is longer and m...
Career Expert Warns Overusing AI Could Weaken Workers’ Skills
A leading career expert warns that overreliance on AI could dull judgment and make skilled workers more vulnerable to...
Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status